Company Filing History:
Years Active: 2022-2023
Title: Innovations by Inventor Lingyu Cai
Introduction
Lingyu Cai is a notable inventor based in Xiamen, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral soluble films. His innovative work has led to the filing of two patents, showcasing his expertise and dedication to advancing medical technology.
Latest Patents
Lingyu Cai's latest patents focus on the preparation of aripiprazole oral soluble films. The first patent describes a method for creating an aripiprazole oral soluble film that contains 10-60% w/w of aripiprazole in a crystalline state and 30-95% w/w of one or more film-forming materials. The film is designed to ensure that 90% of the aripiprazole particles are sized at or below 14.3 micrometers, allowing for a uniform blend without visible undispersed particles. This formulation is noted for its excellent bioavailability, uniformity, stability, and palatability. The preparation process involves grinding aripiprazole particles to achieve the desired size, blending them with film-forming materials in an aqueous solution, defoaming the mixture, and then coating and drying it to form the final film.
Career Highlights
Lingyu Cai is currently associated with Xiamen LP Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has not only contributed to the company's portfolio but has also advanced the field of drug delivery systems.
Collaborations
Lingyu Cai collaborates with talented individuals such as Rongbin Ling and Fuxiang Lin, who contribute to his research and development efforts. Their teamwork enhances the innovative processes within their projects.
Conclusion
Lingyu Cai's contributions to the development of aripiprazole oral soluble films exemplify his commitment to innovation in pharmaceuticals. His patents reflect a significant advancement in drug formulation technology, which can greatly benefit patients.